Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 14 | 2024 | 3785 | 2.010 |
Why?
|
RNA, Small Interfering | 11 | 2019 | 3421 | 1.540 |
Why?
|
Nanoparticles | 12 | 2017 | 1964 | 1.320 |
Why?
|
Islets of Langerhans Transplantation | 10 | 2015 | 746 | 1.210 |
Why?
|
Islets of Langerhans | 12 | 2017 | 1349 | 1.130 |
Why?
|
Doxorubicin | 5 | 2017 | 2230 | 1.110 |
Why?
|
Molecular Imaging | 6 | 2017 | 822 | 1.100 |
Why?
|
Oligonucleotides | 3 | 2020 | 561 | 1.000 |
Why?
|
Carbocyanines | 6 | 2024 | 177 | 0.930 |
Why?
|
Magnetic Resonance Imaging | 26 | 2024 | 36532 | 0.750 |
Why?
|
Ferric Compounds | 5 | 2016 | 368 | 0.740 |
Why?
|
RNA Interference | 5 | 2021 | 2832 | 0.740 |
Why?
|
Magnetite Nanoparticles | 5 | 2019 | 309 | 0.700 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2017 | 1118 | 0.680 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17075 | 0.660 |
Why?
|
Pancreas | 5 | 2019 | 1700 | 0.640 |
Why?
|
Biosensing Techniques | 2 | 2016 | 642 | 0.620 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2019 | 122 | 0.620 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21056 | 0.560 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2019 | 647 | 0.530 |
Why?
|
Mucin-1 | 6 | 2016 | 531 | 0.530 |
Why?
|
Drug Carriers | 2 | 2019 | 700 | 0.510 |
Why?
|
Neoplastic Stem Cells | 2 | 2024 | 1352 | 0.510 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2016 | 52 | 0.500 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2013 | 202 | 0.490 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 752 | 0.470 |
Why?
|
Spectroscopy, Near-Infrared | 4 | 2009 | 750 | 0.460 |
Why?
|
Chickens | 3 | 2015 | 842 | 0.460 |
Why?
|
Mice | 45 | 2024 | 81819 | 0.460 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2822 | 0.450 |
Why?
|
Microscopy, Fluorescence | 9 | 2016 | 2627 | 0.430 |
Why?
|
Nanocapsules | 1 | 2014 | 92 | 0.420 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3608 | 0.410 |
Why?
|
Cell Movement | 4 | 2024 | 5194 | 0.410 |
Why?
|
Adenocarcinoma | 5 | 2013 | 6364 | 0.380 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 679 | 0.380 |
Why?
|
Magnetics | 2 | 2012 | 585 | 0.380 |
Why?
|
Animals | 52 | 2024 | 168764 | 0.370 |
Why?
|
Neoplasms, Experimental | 2 | 2014 | 1229 | 0.360 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8611 | 0.330 |
Why?
|
Subrenal Capsule Assay | 1 | 2009 | 27 | 0.330 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5444 | 0.330 |
Why?
|
Oxides | 3 | 2009 | 402 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2010 | 3446 | 0.310 |
Why?
|
Drug Delivery Systems | 5 | 2017 | 2207 | 0.310 |
Why?
|
Spectrum Analysis, Raman | 1 | 2010 | 252 | 0.310 |
Why?
|
Neoplasm Metastasis | 5 | 2024 | 4893 | 0.300 |
Why?
|
Brain Neoplasms | 5 | 2024 | 9071 | 0.290 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1758 | 0.290 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18293 | 0.290 |
Why?
|
Neoplasms | 7 | 2020 | 22340 | 0.280 |
Why?
|
Isoantigens | 2 | 2015 | 562 | 0.280 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 403 | 0.280 |
Why?
|
Iron | 5 | 2014 | 1816 | 0.260 |
Why?
|
Gene Expression | 2 | 2016 | 7584 | 0.260 |
Why?
|
Zinc | 1 | 2010 | 675 | 0.260 |
Why?
|
Apoptosis | 6 | 2019 | 9514 | 0.250 |
Why?
|
Nanostructures | 1 | 2010 | 548 | 0.250 |
Why?
|
Insulin-Secreting Cells | 2 | 2011 | 898 | 0.250 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1066 | 0.240 |
Why?
|
Dextrans | 5 | 2024 | 571 | 0.240 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2120 | 0.220 |
Why?
|
Cell Proliferation | 5 | 2024 | 10429 | 0.220 |
Why?
|
Eimeria tenella | 1 | 2003 | 3 | 0.220 |
Why?
|
Coccidiosis | 1 | 2003 | 10 | 0.220 |
Why?
|
Poultry Diseases | 1 | 2003 | 24 | 0.220 |
Why?
|
Mice, Nude | 6 | 2016 | 3618 | 0.220 |
Why?
|
Cecal Diseases | 1 | 2003 | 49 | 0.210 |
Why?
|
Peptides | 6 | 2012 | 4331 | 0.210 |
Why?
|
Immunotherapy | 1 | 2019 | 4752 | 0.210 |
Why?
|
Mucins | 1 | 2006 | 567 | 0.210 |
Why?
|
Sarcoma, Avian | 1 | 2002 | 3 | 0.200 |
Why?
|
Microcirculation | 1 | 2007 | 1280 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 3 | 2024 | 462 | 0.200 |
Why?
|
Fluorescence | 3 | 2017 | 753 | 0.190 |
Why?
|
Gene Silencing | 2 | 2010 | 1505 | 0.190 |
Why?
|
Staining and Labeling | 1 | 2006 | 1072 | 0.190 |
Why?
|
Contrast Media | 8 | 2016 | 5329 | 0.190 |
Why?
|
Models, Biological | 1 | 2017 | 9443 | 0.180 |
Why?
|
Histocompatibility Antigens | 1 | 2002 | 477 | 0.180 |
Why?
|
Fluorescent Dyes | 5 | 2017 | 1930 | 0.180 |
Why?
|
Hyperglycemia | 2 | 2008 | 1393 | 0.180 |
Why?
|
Cell Survival | 3 | 2020 | 5747 | 0.170 |
Why?
|
Gadolinium | 3 | 2012 | 965 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2024 | 498 | 0.170 |
Why?
|
Fluorescein-5-isothiocyanate | 2 | 2011 | 220 | 0.170 |
Why?
|
Diagnostic Imaging | 3 | 2009 | 3529 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11868 | 0.160 |
Why?
|
Gadolinium DTPA | 2 | 2012 | 823 | 0.160 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.150 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6220 | 0.150 |
Why?
|
Female | 28 | 2024 | 396112 | 0.150 |
Why?
|
Molecular Probes | 3 | 2009 | 307 | 0.150 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3602 | 0.150 |
Why?
|
Graft Rejection | 4 | 2015 | 4499 | 0.150 |
Why?
|
Humans | 42 | 2024 | 765968 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 720 | 0.140 |
Why?
|
Liver Transplantation | 1 | 2009 | 2412 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2014 | 5881 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 898 | 0.130 |
Why?
|
Avian Proteins | 1 | 2015 | 77 | 0.120 |
Why?
|
Glioblastoma | 2 | 2024 | 3459 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4642 | 0.120 |
Why?
|
Indocyanine Green | 1 | 2017 | 235 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2019 | 889 | 0.110 |
Why?
|
Nanomedicine | 1 | 2017 | 286 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2016 | 341 | 0.110 |
Why?
|
Infrared Rays | 2 | 2005 | 246 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1333 | 0.110 |
Why?
|
Base Pairing | 1 | 2014 | 139 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13648 | 0.110 |
Why?
|
Mice, Inbred NOD | 5 | 2012 | 1837 | 0.110 |
Why?
|
Cell-Free System | 1 | 2014 | 339 | 0.110 |
Why?
|
Ribonucleases | 1 | 2014 | 265 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2019 | 962 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 8923 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 798 | 0.100 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6547 | 0.100 |
Why?
|
Streptozocin | 2 | 2015 | 189 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6113 | 0.100 |
Why?
|
Dacarbazine | 1 | 2014 | 552 | 0.090 |
Why?
|
Chelating Agents | 2 | 2010 | 380 | 0.090 |
Why?
|
Biological Availability | 1 | 2012 | 385 | 0.090 |
Why?
|
Sphingomyelins | 1 | 2011 | 102 | 0.090 |
Why?
|
Salts | 1 | 2010 | 60 | 0.090 |
Why?
|
Blotting, Western | 3 | 2012 | 5020 | 0.090 |
Why?
|
Ferrosoferric Oxide | 2 | 2009 | 349 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9550 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2048 | 0.090 |
Why?
|
Drug Stability | 1 | 2010 | 288 | 0.090 |
Why?
|
Transfection | 2 | 2016 | 5743 | 0.090 |
Why?
|
Fluorine Compounds | 1 | 2009 | 7 | 0.080 |
Why?
|
Particle Size | 1 | 2014 | 1631 | 0.080 |
Why?
|
Fibrin | 1 | 2012 | 513 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1885 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 2012 | 879 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1042 | 0.080 |
Why?
|
Curcumin | 1 | 2009 | 97 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2015 | 3081 | 0.080 |
Why?
|
Image Enhancement | 2 | 2010 | 2858 | 0.080 |
Why?
|
Mice, SCID | 3 | 2012 | 2630 | 0.070 |
Why?
|
Boron Compounds | 1 | 2009 | 196 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1151 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3559 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11083 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2887 | 0.070 |
Why?
|
Papio | 1 | 2009 | 671 | 0.070 |
Why?
|
Pentetic Acid | 1 | 2007 | 208 | 0.070 |
Why?
|
Cell Cycle | 1 | 2015 | 2920 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2012 | 22332 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6942 | 0.070 |
Why?
|
Gold | 1 | 2010 | 482 | 0.070 |
Why?
|
Lymphocytes | 2 | 2015 | 2599 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1599 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3946 | 0.060 |
Why?
|
Antigens | 1 | 2011 | 1438 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 920 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2006 | 111 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2927 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1083 | 0.060 |
Why?
|
Annexin A5 | 1 | 2005 | 102 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3801 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2394 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2005 | 151 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5337 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 820 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2006 | 305 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11206 | 0.060 |
Why?
|
Liposomes | 1 | 2008 | 788 | 0.060 |
Why?
|
Breast | 1 | 2012 | 1946 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13400 | 0.050 |
Why?
|
Disease Progression | 2 | 2012 | 13632 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2010 | 1375 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2060 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1426 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17594 | 0.050 |
Why?
|
Coloring Agents | 1 | 2005 | 564 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5929 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2009 | 1470 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2120 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1354 | 0.050 |
Why?
|
Angiography | 1 | 2007 | 1581 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11022 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8529 | 0.050 |
Why?
|
Fluorouracil | 1 | 2006 | 1648 | 0.050 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 1966 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2699 | 0.040 |
Why?
|
Water | 1 | 2005 | 1417 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 1037 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9249 | 0.040 |
Why?
|
Rats | 2 | 2011 | 23707 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2888 | 0.040 |
Why?
|
Insulin | 2 | 2011 | 6599 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 2002 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2017 | 2266 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20124 | 0.040 |
Why?
|
Blood Glucose | 2 | 2015 | 6424 | 0.040 |
Why?
|
Graft Survival | 1 | 2008 | 3890 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16721 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2226 | 0.030 |
Why?
|
Indoles | 1 | 2005 | 1839 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1789 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 3111 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 3896 | 0.030 |
Why?
|
Glycosylation | 2 | 2012 | 1100 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3236 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2015 | 32 | 0.030 |
Why?
|
Haplotypes | 1 | 2002 | 2728 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 2014 | 29 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3493 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4562 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
Kidney | 1 | 2009 | 7066 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 65188 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5125 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 12240 | 0.030 |
Why?
|
Molecular Structure | 2 | 2009 | 1885 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2355 | 0.030 |
Why?
|
Sialyltransferases | 1 | 2012 | 83 | 0.030 |
Why?
|
Neuraminidase | 1 | 2012 | 190 | 0.020 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2012 | 175 | 0.020 |
Why?
|
Fumonisins | 1 | 2011 | 10 | 0.020 |
Why?
|
Chromatography | 1 | 2011 | 187 | 0.020 |
Why?
|
Toxins, Biological | 1 | 2011 | 60 | 0.020 |
Why?
|
Cell Line | 3 | 2011 | 15543 | 0.020 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 66 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3807 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 545 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9525 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11888 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2010 | 70 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2260 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5891 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 166 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1701 | 0.020 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 120 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 281 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 13024 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14652 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 731 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 562 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1187 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 29922 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4860 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2395 | 0.020 |
Why?
|
Male | 4 | 2016 | 363698 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2006 | 696 | 0.020 |
Why?
|
beta-Alanine | 1 | 2005 | 83 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1957 | 0.010 |
Why?
|
Acute Disease | 1 | 2015 | 7232 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2005 | 473 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1078 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27171 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2005 | 697 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4209 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2548 | 0.010 |
Why?
|
Astrocytes | 1 | 2010 | 1345 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 1526 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3160 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5302 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2423 | 0.010 |
Why?
|
Polymers | 1 | 2008 | 1621 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3715 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3315 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 18071 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40065 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9296 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12403 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15398 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12795 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12768 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1806 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3584 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2475 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 5995 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18973 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11641 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39193 | 0.010 |
Why?
|